Efficacy of the combination of venetoclax and hypomethylating agents in the treatment of patients with primary, relapsed and/or refractory acute myeloid leukemia
Vestnik medicinskogo instituta «Reaviz». Reabilitaciâ, vrač i zdorovʹe/Vestnik medicinskogo instituta "REAVIZ". Reabilitaciâ, vrač i zdorovʹe